Episurf Medical AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 4.6 million compared to SEK 4.7 million a year ago. Net loss was SEK 28.9 million compared to SEK 19.4 million a year ago. Basic loss per share from continuing operations was SEK 0.11 compared to SEK 0.07 a year ago. Diluted loss per share from continuing operations was SEK 0.11 compared to SEK 0.07 a year ago.
For the six months, sales was SEK 9.8 million compared to SEK 9.2 million a year ago. Net loss was SEK 52.1 million compared to SEK 35.8 million a year ago. Basic loss per share from continuing operations was SEK 0.2 compared to SEK 0.13 a year ago. Diluted loss per share from continuing operations was SEK 0.2 compared to SEK 0.13 a year ago.